Integrated smart technology builds on TempraMed's proven VIVI platform, providing robust Temperature control with medication management for individuals using life-saving medicationHighlights: Expands ...
California health care faced major cuts in 2025 as federal Medicaid funding dropped and ACA subsidies stalled, threatening millions.
Jonty Brown became one of the first people to get an "artificial pancreas" from the NHS - and is now an ultramarathon runner.
TipRanks on MSN
TempraMed unveils VIVI Cap Smart to pair drug temperature protection with digital health tools
TempraMed Technologies Ltd. ( ($TSE:VIVI) ) has shared an update. TempraMed Technologies Ltd., a med‑tech firm focused on temperature-controlled ...
The "Liraglutide and Semaglutide - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Liraglutide and Semaglutide was valued at US$17.1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback